Top psych stories of May: Prescription psilocybin, effectiveness of ketamine and more
Click Here to Manage Email Alerts
Healio Psychiatry has compiled a list of its five most-viewed stories in May.
A presentation on the possibility of prescription psilocybin for depression becoming available within 3 years, a study on face covering among children with autism or ADHD and a presentation on outcomes among lesbian and gay children based on consistency in their parents’ views on their sexuality were some of the most-read stories on Healio Psychiatry for the month.
Speaker: Prescription psilocybin for depression, anxiety may be available in 3 to 5 years
Stephen Ross, MD, associate director of NYU Langone Center for Psychedelic Medicine, provided an overview of data on psilocybin for treating depression and anxiety at the American Psychiatric Association’s annual meeting. Read more.
Children with autism, ADHD capable of face covering during COVID-19 pandemic
School-aged children with autism spectrum disorder and/or ADHD were capable of face covering across activities during the COVID-19 pandemic, according to results of a cohort study published in JAMA Network Open. Read more.
Lesbian, gay kids have better outcomes if parents have consistent view of their sexuality
Lesbian and gay children whose parents had a consistent perspective on the child’s sexual orientation, even if that perspective was negative, had better outcomes than those whose parents had changing perspectives. Read more.
Ketamine, esketamine effective for depression but have limitations
Clinical data support the effectiveness of ketamine and esketamine for difficult-to-treat depression and major depressive disorder with suicidal ideation, according to a presenter at the American Psychiatric Association annual meeting. Read more.
Alcohol use disorder has more stigma surrounding it than do other mental health conditions
Stigmatization surrounding alcohol use disorder is high compared with most other mental health conditions, according to results of a systematic review published in Alcoholism: Clinical & Experimental Research. Read more.